Prognosis (HCV)

Cirrhosis More Frequent in Transfusion-Acquired HCV

Published in Blood Weekly, September 1st, 1997

An epidemiological study of more than 6,600 patients with hepatitis C virus-related liver disease confirms that cirrhosis is more common in blood recipients than in drug users.

Researchers found that patients who were infected with hepatitis C virus (HCV) through blood transfusions were three times as likely to develop cirrhosis as intravenous drug users, independent of length of infection.

Francoise Roudot-Thoraval and colleagues suggested that these findings could have a significant impact on the future of HCV related disease, as blood screening results in fewer and fewer transfusion-associated transmissions ("Epidemiological Factors Affecting the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1997-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry